One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune.Born from DeepMind’s AlphaFold breakthrough, the company is ...

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...

On a rare sunny day in London at the Google DeepMind office, Colin Murdoch saw the bank deposit from his employer come through. It wasn't his paycheck. Google was investing in his startup. The ...

Colin Myler, who last served as editor-in-chief at Rupert Murdoch’s scandal-sunken News of the World, has been named to the top spot at the New York Daily News, according to a memo obtained by ...

The paper's newly appointed editor-in-chief is about to take on his old boss Rupert Murdoch's New York Post. By Mimi Turner Colin Myler London High Court - H 2012 As the former News of The World ...